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Abstract
This study describes an innovative self-regulated degrading material with gradual in situ pore formation ability for bone tissue engi-
neering applications. This approach is based on the incorporation of the lysozyme enzyme into calcium phosphate (CaP) coatings, pre-
pared on the surface of chitosan scaﬀolds by means of a biomimetic coating technique with the aim of controlling their degradation rate
and subsequent formation of pores. However, because lysozyme has antibacterial properties, these coatings may act as a carrier for its
sustained release, preventing infection upon implantation. In order to prove the concept of in situ pore formation, the coated scaﬀolds
(with and without lysozyme) were incubated in two diﬀerent solutions at diﬀerent pH to simulate normal physiological conditions (pH
7.4) and inﬂammatory response (pH 5). The weight loss and morphology of the scaﬀolds was monitored over time. At pH 7.4, the scaf-
folds remained more stable than at pH 5. The scaﬀolds incubated at pH 5 showed a rapid decrease in their initial weight, and scanning
electron microscopy imaging revealed the formation of a highly porous structure. Furthermore, evaluation of the activity of the incor-
porated lysozyme revealed that the enzyme was able to hydrolyse the peptidoglycan of the bacteria cell walls (as detected by the decrease
in optical density with time), indicating that the enzyme remained active after being incorporated into the CaP coating.
 2009 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
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1. Introduction
A novel concept in tissue engineering which proposes
in situ pore-forming scaﬀolds has been reported previously
[1]. Chitosan has been considered a promising material for
tissue engineering applications. It is a linear copolymer of
N-acetyl-D-glucosamine and D-glucosamine, derived from
chitin by a deacetylation reaction. The degree of deacetyla-
tion (DD) measures the percentage of glucosamine units in
the polymer chain and inﬂuences its physicochemical prop-
erties such as solubility, crystallinity and swelling behavior,
and its biological properties [2], namely osteogenesis
enhancement [3]. The degradation kinetics appear to be
inversely related to the DD [4]. It has been demonstrated
that chitosan is degraded in vitro and in vivo by lysozyme
[4,5], an enzyme ubiquitous in the human body [6,7]. Lyso-
zyme can attack cell wall polysaccharides of diﬀerent bac-
terial species, especially Gram-positive bacteria, leading
to rupture of the cell wall and killing of the micro-organism
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[8,9]. This study proposes the incorporation of the lyso-
zyme enzyme into calcium phosphate (CaP) coatings, pre-
pared on the surface of chitosan scaﬀolds by means of a
biomimetic coating technique, with the aim of controlling
their degradation rate and subsequent formation of pores.
Furthermore, since lysozyme has antibacterial properties,
these coatings may act as a carrier for its sustained release,
preventing infection upon implantation. An improvement
in the osteoconductivity of implants has been achieved by
coating their surfaces with CaP layers [10–12]. The biomi-
metic methodology for coating biomaterials with a bone-
like apatite layer has been described in several publications
[13–17]. This technique mimics natural biomineralization
processes, involving controlled crystal nucleation and
growth control over the phase of the mineral deposited
[18]. The main advantage of the biomimetic methodology
is the use of physiological conditions (pH 7.4 at 37 C) sim-
ulating the manner in which apatite is formed in bone.
Moreover, this technique allows the incorporation of pro-
teins and bioactive agents into CaP coatings without com-
promising their activity [19–22]. An ideal material for the
purpose of a temporary support for bone replacement
should feature an adequate range of mechanical properties
with convenient degradation kinetics, bone-bonding behav-
ior and biocompatible performance [23].
In order to enhance the formation of pores in situ, chito-
san scaﬀolds coated with CaP layers and lysozyme incorpo-
rated into the coatings were developed, presenting
properties that promote degradation and osteoconductive
potential. Lysozyme enzyme was incorporated into CaP
coatings on the surface of chitosan scaﬀolds by means of
a biomimetic route [13,14,22]. Moreover, CaP coatings
enhance the osteoconductive properties of the chitosan
scaﬀolds.
This study was designed to answer the following ques-
tions: Can a hydrolytic enzyme be incorporate at the sur-
face of chitosan scaﬀolds without compromising its
activity? Is it possible to develop a non-porous scaﬀold
with in situ pore-forming ability? How many days does it
takes to have a porous scaﬀold in situ fully interconnected
simulating in vivo conditions?
2. Materials and methods
2.1. Materials
Chitosan with a DD of 92% and medium molecular
weight was obtained from Sigma (St. Louis, USA). Bio-
glass 45S5 with composition 45SiO2, 24.5CaO, 24.5Na2O
and 6.0P2O5 (in wt.%) was supplied by NovaMin Technol-
ogy Inc. (Alachua, FL).
2.2. Preparation of chitosan scaﬀolds
Chitosan scaﬀolds were prepared as previously described
byMartins et al. [1]. Brieﬂy, chitosan was dissolved in acetic
acid 1% (v/v) to obtain a 5% (w/v) solution. Then, the solu-
tion was cast into polyethylene moulds and frozen (18 C)
overnight. After that, they were immersed in a precipitation
solution (25% NaOH 1 M and 75% Na2SO4 0.5 M) over-
night, adapted from the method developed by Tuzlakoglu
et al. [24]. After precipitation, the samples were washed sev-
eral times with distilled water and dried at 37 C.
2.3. Preparation of CaP biomimetic coatings
The method of preparing the CaP coatings was based on
the methodology previously developed by Abe et al. [13]
and adapted by Reis et al. [14,15], consisting in impregna-
tion of the materials with bioactive glass called Bioglass
45S5, followed by immersion in a simulated body ﬂuid
(SBF, 37 C, pH 7.4), presenting ionic concentrations sim-
ilar to human blood plasma. Prior to the coating process,
chitosan scaﬀolds were sterilized by ethylene oxide. Bio-
glass 45S5 was sterilized by immersion in ethanol solution
(70% v/v) and then dried inside the hood. All the subse-
quent work was performed under sterile conditions in a
hood. Brieﬂy, chitosan scaﬀolds were rolled in a wet bed
of Bioglass 45S5. After that, the scaﬀolds were immersed
in a 1.0 SBF solution, without (control) and with lysozyme
(1 g L1) from chicken egg white (Fluka, USA), for 7 days
at 37 C, a period known as the nucleation stage, which
allows CaP nuclei formation. After the nucleation stage,
all samples were washed with distilled water and immersed
in a concentrated 1.5 SBF solution for 3, 7 and 14 days at
37 C, in order to enhance CaP nuclei growth. All the solu-
tions were sterilized by ﬁltration prior to use. After each
time period, chitosan scaﬀolds were washed with distilled
water and dried until surface characterization was per-
formed. The morphology of the CaP coatings obtained
was analysed by scanning electron microscopy (SEM;
Leica Cambridge S-360, UK). Prior to microstructure anal-
ysis, specimens were coated with gold using a Fisons
Instruments Coater (Polaron SC 502, UK). In order to
characterize the crystalline/amorphous nature of the ﬁlms,
thin-ﬁlm X-ray diﬀraction (TF-XRD; Philips X’Pert MPD,
The Netherlands) was used. Data collection was performed
by the 2h scan method with 1 as the incident beam angle,
using a Cu Ka X-ray line and a scan speed of 0.05 min1
in 2h. In addition, infrared analysis (FTIR) of the coatings
was performed in a Perkin-Elmer spectrometer (Perkin-
Elmer 1600 series equipment, USA) to examine the chemi-
cal structure of the CaP biomimetic coatings obtained.
Coatings were scraped from the chitosan scaﬀolds, mixed
with KBr (Riedel-de Hae¨n, Germany) and then formed
into a disc in a press. All spectra were obtained between
4400 and 450 cm1 at a resolution of 2 cm–1.
2.4. Degradation studies
In order to simulate in vivo conditions, degradation
studies were carried out by incubating uncoated chitosan
scaﬀolds and CaP-coated chitosan scaﬀolds, with and with-
out incorporated lysozyme, in two diﬀerent buﬀer solu-
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tions: (i) Tris–HCl buﬀer (0.22 mM, pH 7.4) to simulate the
normal pH found in human body; and (ii) citrate buﬀer
(1.0 mM, pH 5.0) to simulate the inﬂammatory response
at 37 C for diﬀerent periods of time. At the end of each
degradation period, the samples were removed, washed
with distilled water and dried for later calculation of weight
loss (Eq. (1)). The morphology of the scaﬀolds after degra-
dation was analysed by SEM.
Weight loss ð%Þ ¼ ðInitial weight
 Final weightÞ=Initial weight ð1Þ
2.5. Determination of lysozyme activity in solution and
released from the CaP coatings
In order to evaluate the lysozyme activity and that
released from the CaP coating at pH 5 and pH 7.4, the
Micrococcus lysodeikticus assay was used. This assay is
based on the ability of lysozyme to hydrolyse the cell wall
fragments of bacteria. For determining the activity of
released lysozyme, coated scaﬀolds with incorporated lyso-
zyme were immersed in buﬀer solution (pH 7.4) and incu-
bated at 37 C for 30 days. The released lysozyme
(150 lL) was added to 100 lL of Micrococcus lysodeikticus
suspension (2.3 mg mL1, pH 7.4) in a 96-well plate. The
decrease in turbidity at 37 C was measured at 450 nm
(Microplate Reader, Synergy HT, BIO-TEK Instruments,
Inc., USA) at 1-min intervals for 30 min. The same proce-
dure was used to determine the enzyme activity at pH 5 and
pH 7.4. For that, known enzyme concentrations were pre-
pared in buﬀers at pH 5 and pH 7.4 and added to the bac-
teria suspension in the same buﬀer. The initial kinetic rate
(OD slope at t = 0) was measured for each sample, and a
standard curve (lysozyme activity vs lysozyme concentra-
tion) was constructed. The lysozyme activity released after
30 days was determined from the standard curve.
2.6. Statistics
Results of weight loss are expressed as mean ± standard
deviation with n = 3 for each group. The statistical signiﬁ-
cance of diﬀerences was determined using Student’s t-test
multiple comparison procedure at a conﬁdence interval of
95% (p < 0.05).
3. Results and discussion
3.1. Development of CaP biomimetic coatings
Fig. 1 shows SEM images of the uncoated chitosan scaf-
fold (Fig. 1A) and CaP-coated chitosan scaﬀolds after
immersion in SBF solution in the presence (Fig. 1C and
E) and absence (Fig. 1B and D) of lysozyme. At the nucle-
ation stage, it is possible to observe for both conditions
(with and without lysozyme) the formation of apatite
nuclei (Fig. 1B and C). Lysozyme incorporation in the
nucleation stage did not signiﬁcantly aﬀect the morphology
of the coatings (Fig. 1C). In the ﬁrst 7 days of the growth
stage for both conditions, it is possible to observe that
the size of CaP nuclei increased, forming a dense and com-
pact CaP ﬁlm. This means that immersion in SBF solution
promotes the growth of the CaP layer over time. At higher
magniﬁcations, after 7 days of growth, the morphology of
the coatings is similar in the presence and absence of
lysozyme, demonstrating typical cauliﬂower morphology
(Fig. 1D1 and E1). Lysozyme incorporation into the
coatings did not aﬀect the morphology and growth of the
coatings as a function of immersion time.
Fig. 2A presents the IR spectra of CaP coatings with
and without lysozyme (control) at nucleation stage. Analy-
sis of CaP coatings in the absence of lysozyme shows the
presence of phosphate (PO4
3) groups (bands at 1055,
602 and 556 cm1). Moreover, the presence of carbonate
(CO3
2) bands (1492 and 1441 cm–1) was detected. When
lysozyme was added at the nucleation stage, the same phos-
phate and carbonate groups were also detected (Fig. 2A).
In the spectrum of CaP coating with lysozyme, the appear-
ance of an amide I band (1656 cm–1) was observed, indicat-
ing that lysozyme is incorporated in the coating. The amide
I band represents the stretching vibrations of C@O bonds
in the backbone of the proteins [22,25]. FTIR spectra of
both CaP coatings, with and without lysozyme, conﬁrmed
an apatite layer formation on the surface of the scaﬀolds,
with similar composition of the major mineral component
of the bone [26].
TF-XRD analyses were performed to determine whether
the CaP coatings were crystalline or amorphous. Fig. 2B
shows TF-XRD patterns of CaP coatings in the absence
and presence of lysozyme. No crystalline peaks were
detected for CaP-coated chitosan scaﬀolds with or without
incorporated lysozyme at the nucleation stage (Fig. 2Bb
and Bc). After 7 days of growth, two characteristic peaks
of hydroxyapatite are visible in the diﬀraction patterns of
CaP coatings in the presence and absence of lysozyme,
which are conﬁrmed by comparison with an XRD pattern
of standard hydroxyapatite (JCPDS 9–432) (Fig. 2Bd and
Be). These TF-XRD patterns conﬁrm the formation of
an apatite layer owing to the presence of apatite peaks.
However, the apatite formed appears to be mainly amor-
phous. These results together with FTIR spectra suggest
that the mineral formed is a carbonate apatite mineral sim-
ilar to the major mineral component of bone.
3.2. Degradation studies
The degradation behavior of the chitosan scaﬀolds
developed (uncoated chitosan scaﬀolds, CaP-coated chito-
san scaﬀolds with and without incorporated lysozyme)
was investigated by incubation in buﬀer solutions for diﬀer-
ent periods of time. To simulate in vivo conditions and the
ability of in situ pore formation, two diﬀerent pHs were
tested: pH 7.4 to simulate normal physiological conditions;
and pH 5 to simulate inﬂammatory response.
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On analysis of the weight loss proﬁle at pH 7.4 (Fig. 3A),
all scaﬀolds presented gradual weight loss as a function of
degradation time. The lowest weight loss was observed for
uncoated chitosan scaﬀolds, with almost 4% after 60 days.
The corresponding SEM images show an increase in the sur-
face roughness as a function of immersion time (Fig. 4D, G
and J). These observations are in accordance with weight
loss results (Fig. 3A). TheCaP-coated chitosan scaﬀolds pre-
sented a signiﬁcant weight loss of 7.6 ± 0.2% after 60 days
(Fig. 3A). SEM images show several changes in the CaP
coatings morphology after only 3 days of immersion at pH
7.4, suggesting that the coatings may be gradually dissolved
with time (Fig. 4E, H and K). CaP-coated chitosan scaﬀolds
with incorporated lysozyme presented the highest weight
loss compared with the other two conditions (uncoated
chitosan and CaP-coated chitosan scaﬀolds), presenting a
signiﬁcant weight loss of 9% after 14 days, which slightly
increases to 11.5 ± 1.0% upon 60 days of immersion
(Fig. 3A). Analysing SEM images (Fig. 4C, F, I andL), some
diﬀerences between the coatings in Tris–HCl pH 7.4 were
observed as a function of immersion time. However, these
diﬀerences are not pronounced when compared with CaP
coatings in the absence of lysozyme. Lysozyme seems to pro-
mote the degradation of chitosan scaﬀolds surfaces, as it is
possible to observe the highest weight loss when lysozyme
is present. These ﬁndings are corroborated by the results of
enzyme activity that showed that the enzyme present on
the coatings was still active after 30 days (Fig. 6A). Never-
Fig. 1. SEM images of the surface of chitosan scaﬀolds (A) uncoated, (B and B1) coated with a CaP layer at nucleation stage and (D and D1) after 7 days
in the growth stage, and (C and C1) coated with CaP layer with incorporated lysozyme at nucleation stage and (E and E1) after 7 days in the growth stage.
The scale bar is 50 lm for images A–E and 5 lm for images B1–E1.
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theless, immersion periods at pH 7.4 up to 30 days induced
roughness in the surface of uncoated chitosan scaﬀolds
(Fig. 4D,G and J), and changes in the CaP coatingmorphol-
ogy (in the case of CaP-coated chitosan scaﬀolds with and
without incorporated lysozyme). However, all scaﬀolds were
coated with a CaP layer, meaning that the coatings are quite
stable at normal physiological pH.
The results of degradation studies performed at pH 5 are
shown in Fig. 3B. The same trend was observed for the
weight loss results at pH 7.4. Coated scaﬀolds with incor-
porated lysozyme exhibited a faster degradation rate, when
compared with the other two conditions (uncoated chito-
san and CaP-coated chitosan scaﬀolds) (Fig. 3B). This indi-
cates the role of this enzyme on the hydrolysis of chitosan.
These results are conﬁrmed by the results of enzyme activ-
ity at pH 5, which show that lysozyme is active at that pH
(Fig. 6B). Independent of the pH, the presence of lysozyme
seems to control the degradation rate of the scaﬀolds.
Analysing the SEM images of uncoated chitosan scaf-
folds after 14 days of degradation at pH 5, it is possible
to observe increased degradation with immersion time
(Fig. 5A, D, G, J and M). After only 3 days, evident
changes are observed on the surface of uncoated chitosan
scaﬀolds (Fig. 6D). This appears to be related to the high
susceptibility of chitosan at acidic pH. In Fig. 5E, H, K
and N, the images of CaP-coated chitosan scaﬀolds after
diﬀerent times at pH 5 are presented. After 1 h almost all
the CaP layer was dissolved (data not shown), and it was
Fig. 2. (A) FTIR spectra of CaP coatings, with and without incorporated lysozyme at nucleation stage. (B) TF-XRD spectra of: (a) uncoated chitosan
scaﬀolds; CaP-coated chitosan scaﬀolds at (b) nucleation stage and (d) after 7 days of growth; (c) CaP-coated chitosan with incorporated lysozyme at
nucleation stage and (e) after 7 days of growth.
Fig. 3. Weight loss proﬁle of uncoated chitosan scaﬀolds, CaP-coated chitosan scaﬀolds and CaP-coated chitosan scaﬀolds with incorporated lysozyme as
a function of immersion time at (A) pH 7.4 and (B) pH 5. *Signiﬁcant diﬀerence between time points for each condition. At pH 7.4, for each time point all
diﬀerences between conditions are signiﬁcant. **Signiﬁcant diﬀerence between conditions at the same time point. The weight loss at pH 5 for chitosan
scaﬀolds is signiﬁcantly diﬀerent when compared with that at pH 7.4.
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non-existent after 1 day of degradation (Fig. 5E). SEM
images evidence the formation of pores after only 1 day,
but the formation of interconnected pores is not clearly vis-
ible (Fig. 5E, H, K and N).
The most interesting results were obtained for CaP-
coated scaﬀolds with incorporated lysozyme (Fig. 5F, I,
L and O). The degradation eﬀect of lysozyme on chitosan
is clearly visible from the emergence of a highly porous
structure with time (Fig. 5F, I, L and O). After 1 h, it is
possible to observe a CaP layer on the surface of scaﬀolds
(data not shown). However, after 1 day, as previously
described, the dissolution of the coatings and pore forma-
tion as a function of degradation time was observed. In this
case, the formation of pores is clearly visible after 7 days,
with a structure having interconnected pores (Fig. 5L and
L1). After 14 days, the scaﬀolds exhibit pores with diame-
ter of 50–300 lm (Fig. 5O1). This pore formation is cor-
roborated by the weight loss results. The CaP-coated
chitosan scaﬀolds with incorporated lysozyme presented
the highest weight loss. In addition, lysozyme activity mea-
surements at pH 5 showed that this enzyme is active.
The incorporation of lysozyme into CaP coatings, grown
on the surface of chitosan scaﬀolds may be used as a strategy
to control their degradation rate better. Both degradation
studies (pH7.4 and pH5) show that the presence of lysozyme
enhanced the degradation of chitosan scaﬀolds. The pH of
the degradation media has a remarkable inﬂuence on CaP
coatings. At pH 7.4, all scaﬀolds remained coated up to
60 days. However, at pH 5, after 1 day, the dissolution of
the coatings and formation of pores was observed mostly
when due to the presence of lysozyme. These results show
that lysozyme has an important role in the degradation of
chitosan scaﬀolds. CaP-coated chitosan scaﬀolds with incor-
porated lysozyme presented the highest values of weight loss
at both pH 7.4 and pH 5. At pH 7.4, no eﬀect of lysozyme on
the scaﬀold morphology was evident. Nevertheless, it
enhanced the formation of a porous structure with intercon-
nected pores at pH 5.
Fig. 4. SEM images of chitosan scaﬀolds, CaP chitosan scaﬀolds and CaP chitosan scaﬀolds with incorporated lysozyme before and after degradation at
pH 7.4 up to 30 days. Scale bar is 50 lm and applies to all images.
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3.3. Lysozyme activity in solution and released from the
coatings
Evaluation of the activity of the lysozyme released from
the coatings (Fig. 6A) revealed that the enzyme was able to
hydrolyze the peptidoglycan of the bacteria cell walls (as
detected by the decrease in optical density with time).
The results of this study (Fig. 6A) showed that the enzyme
remained active after 30 days of immersion in buﬀer solu-
tion (pH 7.4).
Changes in the pH of the environment can alter or inhibit
enzyme activity. In order to conﬁrm that lysozyme is active at
both pH 5 and pH 7.4, known lysozyme concentrations were
used to construct a calibration curve. OD slopes were deter-
mined for diﬀerent lysozyme concentrations (Fig. 6B) and an
increase in enzymatic activity as a function of increasing
lysozyme concentration was observed. Lysozyme is active
at pH 5 and pH 7.4. The OD slope for the ﬁrst 5 min in the
graph was also calculated (Fig. 6A) to determine the lyso-
zyme activity released from the coatings. The activity of lyso-
zyme released from the coatings was 0.0375 U (1 U
corresponds to the amount of enzyme which decreases the
absorbance at 450 nm min–1 at pH 7.4, 37 Cusing a suspen-
sion ofMicrococcus lysodeikticus as substrate).
Fig. 5. SEM images of chitosan scaﬀolds, CaP chitosan scaﬀolds and CaP chitosan scaﬀolds with incorporated lysozyme before and after degradation at
pH 5 up to 14 days. The scale bar is 200 lm for all images except for I1, L1, O1 (50 lm).
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4. Conclusions
In this work, lysozyme was successfully incorporated
into CaP coatings produced on the surface of chitosan scaf-
folds, using a biomimetic technique. Degradation studies at
pH 7.4 to simulate normal physiological conditions showed
that the morphology of uncoated scaﬀolds and CaP coat-
ings changed. However, the formation of pores as a func-
tion of immersion time was not observed. Moreover, CaP
coatings are very stable at pH 7.4 and, after 30 days, all
scaﬀolds remained covered with a CaP layer. At pH 5, to
simulate an in vivo inﬂammatory response, a porous struc-
ture was formed when lysozyme was incorporated into the
CaP coatings. The degradation eﬀect of lysozyme on chito-
san at pH 5 is clearly visible from the appearance of pores.
In addition, at high magniﬁcations, SEM images suggest
that these pores are interconnected. It was also shown that
lysozyme incorporated into the coatings was active after
30 days of immersion in buﬀer solution (pH 7.4). This
approach is very promising, as the presence of lysozyme
incorporated into the coatings will allow chitosan scaﬀolds
with gradual in vivo pore-forming ability and antibacterial
properties that can simultaneously exhibit osteoconductive
properties via the presence of CaP coating to be obtained.
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